Not a part of “Triple therapy” immunosuppression for post-renal transplant patient is:
Correct Answer: Belatacept
Description: Ans. D. BelataceptBelatacept is not part of "Triple therapy" immunosuppression for post-renal transplant patient.* The most frequently used combination is triple therapy with- Prednisone- Calcineurin inhibitor (Tacrolimus - 1st line or Cyclosporine)- Antimetabolite (Mycophenolate mofetil or Azathioprine)* Mammalian TOR (mTOR) inhibitors can replace one of the last two agents.Note: More recently, the U.S. Food and Drug Administration (FDA) approved a new co-stimulatory blocking antibody (CD80 & CD86), belatacept, as a new strategy to prevent long-term calcineurin inhibitor toxicity. It is indicated for prophylaxis of organ rejection in patients who are EBV seropositive and receiving a kidney transplant.
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now